2017 Buick Encore Sport Touring
1.4 L • 4 • FWD • AT
KL4CJ1SB0HB229738
Sales history: 1
Highlights
Condition
Engine starts
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
1.4 L • 4 • FWD • AT
Odometer
68,053 mi ≈ 109,520 km
Primary damage
Rollover
Docs
TN • Salvage
Auction
VIN
KL4CJ1SB0HB229738
Lot number
63836545
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Nashville, TN
Description
Fuel type
Gasoline
Body color
Brown
Body type
SUV
Trim
Sport Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2017 Buick Encore Sport Touring • 1.4 L • 4 cyl • FWD • Automatic • Copart Lot: 63836545 • VIN: KL4CJ1SB0HB229738
Find out more about this 2017 Buick Encore Sport Touring, available at the Copart salvage car auction as lot #63836545 in Nashville, TN. This car has Rollover main damage. It is listed with Engine starts start condition code. Odometer shows 68,053 mi. This Brown Buick Encore SUV is equipped with Gasoline 1.4 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for KL4CJ1SB0HB229738 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
